| 000 | 01753 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515130055.0 | ||
| 264 | 0 | _c20080930 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0021-5155 | ||
| 024 | 7 |
_a10.1007/s10384-008-0510-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKawashima, Miwako | |
| 245 | 0 | 0 |
_aChoroidal folds and retinal pigment epithelium tear following intravitreal bevacizumab injection for exudative age-related macular degeneration. _h[electronic resource] |
| 260 |
_bJapanese journal of ophthalmology _c |
||
| 300 |
_a142-144 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aChoroid Diseases _xetiology |
| 650 | 0 | 4 | _aColoring Agents |
| 650 | 0 | 4 | _aExudates and Transudates |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndocyanine Green |
| 650 | 0 | 4 |
_aInjections _xadverse effects |
| 650 | 0 | 4 |
_aMacular Degeneration _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPigment Epithelium of Eye _xpathology |
| 650 | 0 | 4 | _aRupture, Spontaneous |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aVitreous Body |
| 700 | 1 | _aMori, Ryusaburo | |
| 700 | 1 | _aMizutani, Yoshihiro | |
| 700 | 1 | _aYuzawa, Mitsuko | |
| 773 | 0 |
_tJapanese journal of ophthalmology _gvol. 52 _gno. 2 _gp. 142-144 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10384-008-0510-5 _zAvailable from publisher's website |
| 999 |
_c18107728 _d18107728 |
||